Requesting KRAS makes sense “as a demand” for those patients with more aggressive tumours and should be considered today as an indispensable part of decision making before embarking on aggressive surgical therapy, while in other patients with specific criteria, the KRAS testing could be omitted. Here, KRAS is linked to neoplasm.